Entering text into the input field will update the search result below

Premarket analyst action - healthcare

  • Depomed (DEPO) downgraded to Neutral from Buy with a $17 (0% upside) price target by Mizuho Securities.
  • Invitae (NYSE:NVTA) upgraded to Buy from Hold with an $11 (20% upside) price target by Benchmark.
  • Zosano Pharma (NASDAQ:ZSAN) price target raised to $3.25 (91% upside) from $2.00 by Roth Capital.
  • HealthSouth (HLS) initiated with Buy rating and $48 (18% upside) price target by Craig-Hallum.
  • Dentsply Sirona (NASDAQ:XRAY) upgraded to Buy with a $70 (19% upside) price target by Stifel Nicolaus.
  • Valeant Pharmaceuticals (VRX) price target reduced to $22 (47% upside) by both RBC and Royal Bank of Canada.

Recommended For You

About ASRT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ASRT--
Assertio Holdings, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.